Study of AxoGuard® Nerve Cap and Neurectomy for Treatment of Symptomatic Neuroma & Prevention of Recurrent Neuroma Pain
Completed · Not applicable
Conditions studied: Symptomatic Neuroma, Morton's Neuroma, Chronic Nerve Pain
In brief
Comparing safety, pain, user experience, healthcare economic costs, work productivity, impairment and quality of life outcomes between Axoguard® Nerve Cap and neurectomy in the treatment of symptomatic neuromas in the foot or ankle. Study consists of 86 subjects randomized between the treatment groups followed for 12 months.
Key facts
- Study ID
- NCT03940963
- Run by
- Axogen Corporation
- People needed
- 86
- Starts
- 2018-10-10
- Expected to finish
- 2023-07-17
- Last updated by the study team
- 2025-01-09
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- New Hope Podiatry Group — Los Angeles, California, United States
- Anastasia Medical Group — Saint Augustine, Florida, United States
- EHI Clinical Research — Roswell, Georgia, United States
- Gateway Clinical Trials — O'Fallon, Illinois, United States
- OrthoIllinois — Rockford, Illinois, United States
- Foot and Ankle Center of Illinois — Springfield, Illinois, United States
- The Ohio State University — Columbus, Ohio, United States
- Austin Foot and Ankle Specialists — Austin, Texas, United States
- Complete Foot and Ankle Care of North Texas — Denton, Texas, United States
- JPS Health Network — Fort Worth, Texas, United States
- Foot & Ankle Institute — St. George, Utah, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.